VP Clinical Affairs
Biomaterials
Regentis Biomaterials
Israel
Brooke brings over 25 years of experience in medical devices, ranging from hip, knee and spine implants to neuro monitoring systems and implantable pain delivery systems. Previously she was with Augmenix where she lead a prostate cancer pivotal clinical trial for a hydrogel implant. Prior to Augmenix, she was with DePuy, a Johnson & Johnson Company for 19 years. Brooke has held positions related to new product development in R&D, Clinical Program Management and Clinical Operations. She earned a Bachelor of Science in Mechanical Engineering from Northeastern University, a Masters in Engineering from Worcester Polytechnic Institute, and a Masters of Business Administration from Babson College. She has nineteen patents. In her current position, Brooke is responsible for overseeing the pivotal clinical trial.
Green Chemistry, Sustainability, renewable resources, biomass, biofuel, Green Engineering, green industrial applications, green investments, green process, green energy, biomaterials